Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis
Abstract The precise clinicopathologic significance of myeloid differentiation primary response gene (MYD88) L265P mutation in diffuse large B-cell lymphomas (DLBCLs) remains elusive. To investigate the frequency and clinicopathologic significance of the MYD88 L265P mutation in DLBCLs, we conducted...
Guardado en:
Autores principales: | Ju-Han Lee, Hoiseon Jeong, Jung-Woo Choi, HwaEun Oh, Young-Sik Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/accd3cebac4a4ace9ddfdf9723f0b725 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging targets in human lymphoma: targeting the MYD88 mutation
por: Wang JQ, et al.
Publicado: (2013) -
Identification and function of myeloid differentiation factor 88 (MyD88) in Litopenaeus vannamei.
por: Shuang Zhang, et al.
Publicado: (2012) -
Lipopolysaccharide-induced NF-κB nuclear translocation is primarily dependent on MyD88, but TNFα expression requires TRIF and MyD88
por: Jiro Sakai, et al.
Publicado: (2017) -
MyD88 promotes myoblast fusion in a cell-autonomous manner
por: Sajedah M. Hindi, et al.
Publicado: (2017) -
MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs
por: Shuang Ge, et al.
Publicado: (2021)